IQ 532® Laser System – Dual port green laser for comprehensive ophthalmology

IQ 532® Laser System. Dual port green laser for comprehensive ophthalmology. NEW- MicroPulse® Laser Therapy for repeatable, tissue-sparing* glaucoma and retinal therapies. High power for greater range of therapy alternatives. Dual port for efficient setup of alternate delivery devices. Repeatable laser sessions for retinal diseases with optional MicroPulse module

The Advantages of Innovation

High power for greater range of therapy alternatives
High speed pulse durations for faster procedural time
DualSense provides quick and simple selection of multiple delivery devices for RFID and SMA

Intelligent and intuitive design

Dual Port for efficient setup of alternate delivery devices
Intuitive graphic touch screen interface for ease of use
Programmable memory presets for multiple users

Optional Module for MicroPulse Laser Therapy, Fovea-Friendly*

Repeatable laser sessions for retinal diseases
Repeatable glaucoma therapy with MicroPulse laser trabeculoplasty (MLT)

IQ 532^® Laser System
Wavelength	532 nm Green
Weight	19.2 lb (9.0 kg)
Dimensions	8.5″ H x 12″ W x 14″ D (21 cm x 30 cm x 35 cm)
Connector Type	RFID \| Resistor
Electrical	100-240 VAC, 50/60 Hz
Cooling	Whisper fan
Exposure Duration	CW-Pulse: 10-3000 ms
Exposure Interval	CW-Pulse: 10-3000 ms
MicroPulse Duration	MicroPulse: 0.05-1.00 ms
MicroPulse Interval	MicroPulse: 1.00-10.00 ms
Aiming Laser	Diode laser, 635 nm nominal
Delivery Device Power Output	Portable SLA: 0-2000 mW LIO: 0-2000 mW EndoProbe: 0-2000 mW

Optional Accessories

Full-Featured Remote Control

Compact design for easy placement or use in sterile field
View displays and adjust parameters from two vantage points for increased convenience and efficiency

Wireless Footswitch

No cord, no clutter, no limitations
Allows precise physician control over power settings
Available with power-adjust to control laser actuation and power settings

“The IQ532 Tx Cell Laser System is an invaluable adjunct in my armamentarium for a growing multitude of retinal and choroidal pathologies. In my hands, micropulse laser technology has achieved significant anatomic and functional gains as primary and combination therapy. The TxCell pattern delivery dramatically increases laser application efficiency, as well as patient comfort.”

Caesar Luo, MD Bay Area Retina Associates Oakland, CA USA

Munir Escaf, MD
Retina Specialist. Clinica Carriazo Barranquilla. Atlantico, Columbia

Jonathan Feistman, MD.
Retina Specialist. NYC Retina. New York City, NY

Brian Horsman, MD.
Director, Retina Group. Barnet Dulaney Perkins Eye Center. Phoenix, AZ USA

“The MicroPulse P3 Device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye.”

Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT USA

Brandon Johnson, MD.
NYC Retina. New York, NY USA

Walid Mangal, DO.
Florida Vision Institute Stuart, FL USA

Ahad Mahootchi, MD.
Medical Director The Eye Clinic of Florida Zephyrhills, FL

“By incorporating MicroPulse, my injection burden decreases by one-third at a minimum, which is a conservative estimate. The versatility of MicroPulse to treat retinal disorders and glaucoma allows me to provide my patients with a treatment that’s clinically effective, cost effective, and time effective.””MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications.”

Jason Friedrichs, MD, MS Friedrichs Eye Sycamore, IL USA

“Compared to other lasers, the IQ 532 Laser with the MicroPulse module offers greater versatility because it can also be used for a range of other conditions including diabetic macular edema, proliferative diabetic retinopathy, and retinal tears. I’m comfortable offering MLT to glaucoma patients as a first-line option because of its potential to reduce intraocular pressure without causing tissue damage.”

David Gossage, DO, FAOCO, FAAO Gossage Eye Institute Hillsdale, MI USA